{"Symbol": "BIO", "AssetType": "Common Stock", "Name": "Bio-Rad Laboratories Inc", "Description": "Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.", "CIK": "12208", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "1000 ALFRED NOBEL DRIVE, HERCULES, CA, UNITED STATES, 94547", "OfficialSite": "https://www.bio-rad.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "6920664000", "EBITDA": "431500000", "PERatio": "9.21", "PEGRatio": "1.19", "BookValue": "276.16", "DividendPerShare": "None", "DividendYield": "None", "EPS": "27.86", "RevenuePerShareTTM": "94.69", "ProfitMargin": "0.294", "OperatingMarginTTM": "0.0886", "ReturnOnAssetsTTM": "0.0167", "ReturnOnEquityTTM": "0.108", "RevenueTTM": "2583200000", "GrossProfitTTM": "1343600000", "DilutedEPSTTM": "27.86", "QuarterlyEarningsGrowthYOY": "-0.83", "QuarterlyRevenueGrowthYOY": "0.039", "AnalystTargetPrice": "328", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "2", "AnalystRatingHold": "3", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "9.21", "ForwardPE": "26.88", "PriceToSalesRatioTTM": "2.679", "PriceToBookRatio": "0.928", "EVToRevenue": "2.549", "EVToEBITDA": "5.44", "Beta": "1.18", "52WeekHigh": "343.12", "52WeekLow": "211.43", "50DayMovingAverage": "306.37", "200DayMovingAverage": "282.04", "SharesOutstanding": "21906400", "SharesFloat": "21135100", "PercentInsiders": "16.275", "PercentInstitutions": "94.038", "DividendDate": "None", "ExDividendDate": "None"}